Multiple action compounds in angina pectoris
1Hallstrom Institute of Cardiology, Royal Prince Alfred Hospital, Sydney, Australia.
Zeitschrift Fur Kardiologie
|January 1, 1989
Insights
Carvedilol, a vasodilating beta-blocker, effectively treats angina pectoris by improving exercise tolerance. It offers better outcomes and fewer side effects than traditional beta-blockers and nifedipine, enhancing patient quality of life.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Angina pectoris management often involves beta-blockers or calcium channel blockers.
- Optimizing anti-anginal therapy is crucial for improving patient outcomes and quality of life.
Purpose of the Study:
- To evaluate the efficacy and safety of carvedilol in patients with angina pectoris.
- To compare carvedilol's effectiveness against standard beta-blockers and nifedipine.
Main Methods:
- Multicenter clinical trials were conducted.
- Patient exercise tolerance and side effect profiles were assessed.
Main Results:
- Carvedilol demonstrated comparable efficacy to standard beta-blockers in improving exercise tolerance.
- Carvedilol showed superior efficacy to nifedipine for angina.
- Carvedilol exhibited a more favorable side effect profile than conventional beta-blockers and nifedipine.
Conclusions:
- Carvedilol is an effective anti-anginal therapy.
- Carvedilol improves exercise tolerance and quality of life in angina patients.
- Carvedilol presents a favorable safety profile compared to other anti-anginal agents.
Abstract:
Carvedilol--a vasodilating beta-blocker has been shown in multicentre trials to be as effective as standard beta-blockers in improving exercise tolerance in patients with angina pectoris and it is more effective than nifedipine. The side effects are less than conventional beta-blockers and nifedipine. Carvedilol is an effective anti-anginal therapy and improves the quality of life.
Related Concept Videos
01:16Antianginal Drugs: Nitrates and β-Blockers
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
01:30Angina I: Introduction
Definition and Symptoms: Angina (angina pectoris) is chest pain or discomfort caused by myocardial ischemia, which occurs when the heart muscle receives insufficient oxygen-rich blood. It typically manifests as pressing, squeezing, or crushing sensations in the chest and may radiate to the shoulders, arms, neck, jaw, or back.Primary Cause: In a healthy state, the coronary arteries can dilate (widen) to increase blood flow and meet the increased oxygen demand during physical activity or...
01:27Angina II: Classification
Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
01:26Angina IV: Management
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
01:20Angina V: Nursing Management
Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...